Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Daniela Dalceggio"'
Autor:
Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Caterina Zerbi, Livio Trentin, Alessandro Re, Chiara Rusconi, Simonetta Viviani, Andrea Rossi, Federica Cocito, Barbara Botto, Erika Meli, Antonello Pinto, Irene Dogliotti, Guido Gini, Benedetta Puccini, Francesca Ricci, Luca Nassi, Alberto Fabbri, Anna Marina Liberati, Michele Merli, Andrea Riccardo Filippi, Maurizio Bonfichi, Valentina Zoboli, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Ilaria Del Giudice, Isabel Alvarez, Andrea Visentin, Stefano Pravato, Daniela Dalceggio, Chiara Pagani, Silvia Ferrari, Caterina Cristinelli, Tanja Lazic, Virginia Valeria Ferretti, Umberto Ricardi, Luca Arcaini
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e837 (2023)
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare entity whose neoplastic cells retain a B-cell phenotype with expression of CD20. Radiotherapy is recommended for favorable stage IA disease while for other stages guidelines suggest th
Externí odkaz:
https://doaj.org/article/09f7bb15b7604be5994072aa44cd7825
Autor:
Alessandra Tedeschi, Davide Rossi, Marina Motta, Giulia Quaresmini, Marianna Rossi, Marta Coscia, Antonella Anastasia, Fausto Rossini, Agostino Cortelezzi, Guido Nador, Lydia Scarfò, Roberto Cairoli, Anna Maria Frustaci, Daniela Dalceggio, Paola Picardi, Lorenzo De Paoli, Ester Orlandi, Alessandro Rambaldi, Massimo Massaia, Gianluca Gaidano, Marco Montillo
Publikováno v:
Haematologica, Vol 100, Iss 12 (2015)
Externí odkaz:
https://doaj.org/article/58fbc9dd28544a27806485aeec5df31e
Autor:
Doriana Gramegna, Chiara Pagani, Angela Passi, Erika Borlenghi, Chiara Cattaneo, Claudia Crippa, Francesca Schieppati, Margherita Oberti, Daniela Bellotti, Margherita Sciumé, Elisa Cerqui, Cecilia Carbone, Daniela Dalceggio, Giuseppe Rossi, Diego Bertoli, Mirko Farina, Alessandra Tucci, Silvana Archetti, Giulia Soverini
Publikováno v:
Hematological Oncology. 38:754-762
Consolidation treatment in acute myeloid leukemia (AML) patients achieving complete remission (CR) is warranted. High-dose cytarabine (HDAC) is considered first choice in favorable risk and an option in intermediate-risk AML. However, its optimal dos
Autor:
Cecilia Carbone, Chiara Cattaneo, Daniela Bellotti, Elisa Cerqui, Chiara Pagani, Mirko Farina, Erika Borlenghi, Giuseppe Rossi, Francesca Schieppati, Daniela Dalceggio, Giulia Soverini, Angela Passi, Alessandra Tucci, Silvana Archetti, Diego Bertoli, Margherita Oberti, Margherita Sciumé, Doriana Gramegna, Claudia Crippa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::498d121e14e81986337c17d4dd43cfd4
https://doi.org/10.1002/hon.2806/v2/response1
https://doi.org/10.1002/hon.2806/v2/response1
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19
Autor:
Angelo Belotti, Mariella D'Adda, Chiara Pagani, Erika Borlenghi, Kordelia Barbullushi, Daniela Dalceggio, Alessandro Re, Annalisa Peli, Aldo M. Roccaro, Nicola Bianchetti, Rosa Daffini, Massimo Salvetti, Giuseppe Rossi, Maria Lorenza Muiesan, Alessandra Tucci, Valeria Cancelli, Margherita Oberti, Anna Paini, Valentina Mancini, Roberto Cairoli, Chiara Cattaneo, Carolina De Ciuceis, Antonella Anastasia, Marina Motta
Publikováno v:
Cancer
Background: Patients with cancer are considered highly vulnerable to the recent coronavirus disease 2019 (COVID-19) pandemic. However, there are still few data on COVID-19 occurring in hematologic patients. Methods: One hundred two patients with COVI
Autor:
Chiara, Cattaneo, Doriana, Gramegna, Chiara, Pagani, Erika, Borlenghi, Malagola, Michele, Elisa, Cerqui, Angela, Passi, Schieppati, Francesca, Claudia, Crippa, Daniela, Dalceggio, Cecilia, Carbone, Anna Maria Pelizzari, Margherita, Sciumé, Alessandro, Re, Russo, Domenico, Giuseppe, Rossi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3662::25b521b04acdf2b98b578c8a2733ed9f
http://hdl.handle.net/11379/528191
http://hdl.handle.net/11379/528191
Autor:
Ester Orlandi, Marco Montillo, Marianna Rossi, Lydia Scarfò, Giulia Quaresmini, Gianluca Gaidano, Agostino Cortelezzi, Guido Nador, Antonella Anastasia, Lorenzo De Paoli, Davide Rossi, Marina Motta, Daniela Dalceggio, Anna Maria Frustaci, Fausto Rossini, Marta Coscia, Massimo Massaia, Alessandro Rambaldi, Alessandra Tedeschi, Roberto Cairoli, Paola Picardi
There is a significant need to develop an efficient treatment, without sacrificing efficacy, for older fit patients with chronic lymphocytic leukemia (CLL) as fludarabine, cyclophosphamide and rituximab (FCR) have very often led to treatment-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0110d842fa313a65db51bbd2fd31d034
https://europepmc.org/articles/PMC4666341/
https://europepmc.org/articles/PMC4666341/
Autor:
Paolo Paesano, Maura Brugiatelli, Maria Giuseppina Cabras, Angelo Fama, Michele Spina, Alberto Fabbri, Benedetta Puccini, Giuseppe Rossi, Salvatrice Mancuso, Luigi Rigacci, Flavia Salvi, Paola Riccomagno, Maurizio Martelli, Chiara Bottelli, Caterina Stelitano, Alessandra Tucci, Sergio Storti, Stefano Fogazzi, Daniela Dalceggio, Francesco Bertagna
We performed a multicenter study to validate the concept that a simple comprehensive geriatric assessment (CGA) can identify elderly, non-fit patients with diffuse large B-cell lymphoma (DLBCL) in whom curative treatment is not better then palliation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47816c763d3ab19ec0cd22b5e6124856
http://hdl.handle.net/10807/172552
http://hdl.handle.net/10807/172552
Autor:
Simona Fisogni, Angela Passi, Daniela Dalceggio, Fabio Facchetti, Giuseppe Rossi, Chiara Cattaneo, Piera Balzarini, Alessandro Re, Luisa Lorenzi, Alessandra Tucci, Francesca Schieppati
Publikováno v:
Blood. 128:5295-5295
Background: MYC rearrangements occur approximately in 5-15% of diffuse large B-cell lymphoma (DLBCL), and are known to unfavorably impact on patients (pts) survival, especially if associated to BCL2 or/and BCL6 rearrangements (double/triple-hit). Pre
Autor:
Francesca Schieppati, Claudia Basilico, Laura Marbello, Francesca Guidotti, Silvia Ferrari, Nicola Stefano Fracchiolla, Andrea Ferrario, Matteo Carrabba, Daniela Dalceggio, Giuseppe Rossi, Massimo Bernardi, Chiara Pagani, Erika Borlenghi
Publikováno v:
Blood. 124:953-953
Background: According to the WHO classification, secondary acute myeloid leukemia (s-AML) includes cases occurring in patients (pts) receiving prior antineoplastic treatments as well as cases developing in pts with a history of previous hematology di